In contrast, anti-citrullinated peptide antibody (ACPA) has emerged as an alternative serological test, as it has greater specificity and may be preferable to RF in the diagnosis of RA.1 However, it is not yet generally available in primary care. This evidence concerns the gene PRTN3 and rheumatoid arthritis.